Cargando…
INCREASED RISK OF OCCURRENCE OF NEUROLEPTIC MALIGNANT SYNDROME ON COMBINED TREATMENT WITH LITHIUM AND NEUROLEPTIC
Whether there is an increased risk of occurrence of neuroleptic malignant syndrome (NMS) on combined treatment with lithium and neuroleptic is a controversial issue. Patients seen in a general psychiatry unit of a university hospital in India were prospectively screened for NMS over a 2 year period....
Autores principales: | Alexander, P. John, Thomas, Ranji Mathai |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967123/ https://www.ncbi.nlm.nih.gov/pubmed/21584083 |
Ejemplares similares
-
Neuroleptic malignant syndrome
por: Tan, Carolyn Michelle, et al.
Publicado: (2023) -
NEUROLEPTIC MALIGNANT SYNDROME
por: Jayesh, Kanabar
Publicado: (1997) -
Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016) -
Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006) -
Risk Factors in Neuroleptic Malignant Syndrome
por: Gupta, Vinay, et al.
Publicado: (2003)